Huang Pharmaceutical (00013) released the data of the SACHI phase III study at the American Society of Clinical Oncology (ASCO) annual meeting in 2025.

The Zhitong Finance and Economics APP news, Hutchison Medicine (00013) announced the main results of the mid-term analysis of the SACHI III study. These results were presented in the form of a groundbreaking oral report at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on June 1, 2025 (Sunday).